WeVote
Log In

Bill

Bill

SCR 228

A CONCURRENT RESOLUTION adjourning the General Assembly until March 27, 2025.

2025 Regular Session

SCR 228 directs a DOE pilot to place epinephrine-trained staff in every public/charter school, post anaphylaxis signs, and report findings before 2026 session.

adopted by voice vote
#generalassembly
0
WeVote Research Nonpartisan
Bill Summary · SCR 228

Summary — SCR 228 (Concurrent Resolution)

Status: Adopted by voice vote (introduced Mar 7, 2025)
Classification: Concurrent resolution (non‑binding request)
Primary sponsors: Gabbard, McKelvey; cosponsors listed include Chang, Fevella, Richards
Related: SR 204 (companion)

Purpose / Intent

SCR 228 requests the Department of Education (DOE) to establish a pilot program to improve school‑level readiness to respond to anaphylaxis by making epinephrine‑trained and authorized staff available in each public and charter school, and by posting clear signage about anaphylaxis recognition and epinephrine administration. The resolution is framed to reduce delay in lifesaving treatment and improve outcomes for students and staff with life‑threatening allergies.

Key provisions

  • Requests DOE to establish a pilot program making available, in each DOE public school and charter school, staff who are trained and authorized to administer epinephrine.
  • Staffing minimums (to be applied “to the extent possible”):
    • Place in each school a minimum number of trained/authorized staff equal to the greater of:
    • one trained staff per 100 students; or
    • one trained staff per floor or per each school building that students access.
  • Requires display, in each school building, clearly legible signs stating:
    • the symptoms of anaphylaxis; and
    • the proper method for administering epinephrine.
  • Reporting requirement: DOE is requested to submit findings and recommendations on the pilot, including any proposed legislation, to the Legislature no later than 20 days prior to the convening of the Regular Session of 2026.
  • Directs that a certified copy of the resolution be transmitted to the Superintendent of Education.

Who is affected

  • Public schools operated by the state Department of Education and charter schools.
  • Students and staff with life‑threatening allergies (direct beneficiaries).
  • DOE (administrative responsibility for designing and running the pilot).
  • Potential indirect fiscal/operational effects on schools for training, staffing, supplies (epinephrine auto‑injectors), and signage.

Legal and procedural notes

  • As a concurrent resolution, SCR 228 requests action by an executive agency (DOE) but does not itself create binding statutory obligations or appropriate funds.
  • Language repeatedly qualifies actions with “requested” and “to the extent possible,” indicating discretion for DOE and no mandate to allocate resources beyond existing appropriations.
  • DOE must report back with recommendations (and any proposed legislation) before the 2026 Regular Session.

Potential impact

  • If implemented, the pilot could increase timely epinephrine administration in emergencies, potentially reducing morbidity and mortality from anaphylaxis in schools.
  • Implementation would likely incur costs for staff training, potential staffing adjustments, purchasing epinephrine (if provided), and signage; the resolution does not authorize funding.
  • The required report could lead to proposed statutory changes or budget requests in 2026 based on pilot results.

Note: The materials provided include an alternate/administrative text titled “A CONCURRENT RESOLUTION adjourning the General Assembly until March 27, 2025” (a procedural adjournment resolution). The substantive epinephrine pilot language summarized above is the policy content of SCR 228 requesting DOE action.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.